# US 2006/0153824 A1 · Methods and kits for co-administration of nutritional supplements

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0153824 A1
- Document ID: US20060153824A1
- Status: Published application
- Kind: A1
- Application number: 11/034,105
- Filed: 2005-01-13
- Published: 2006-07-13
- Earliest claimed: 2005-01-13
- Assignees: Everett Laboratories, Inc.
- Inventors: John Giordano; Charles Balzer
- Web page: https://patentgrep.com/patent/US20060153824A1

## CPC

- A61K 31/525: Isoalloxazines, e.g. riboflavins, vitamin B2
- A61K 31/122: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/4415: Pyridoxine, i.e. Vitamin B6 (pyridoxal phosphate A61K31/675)
- A61K 31/455: Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A61K 31/51: Thiamines, e.g. vitamin B1
- A61K 31/714: Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to methods of co-administration of various vitamin and mineral compositions, and in a specific embodiment, comprise co-administering one composition comprising vitamin B6, vitamin B12, folic acid, and CoQ10 and a second composition comprising omega-3 fatty acids for nutritional supplementation in order to prevent, treat and/or alleviate the occurrence or negative effects of cardiovascular disease; and kits provided for co-administration of various vitamin and mineral compositions, and in a specific embodiment, comprise one composition comprising vitamin B6, vitamin B12, folic acid, and CoQ10 and a second composition comprising omega-3 fatty acids for nutritional supplementation in order to prevent, treat and/or alleviate the occurrence or negative effects of cardiovascular disease.

## Claims

### Claim 1

A method comprising co-administering a first composition comprising vitamin B6, vitamin B12, folic acid, and CoQ10 to a patient and a second composition comprising Omega-3 Fatty acids to said patient, in any order.

### Claim 2 (depends on 1)

The method of claim 1, wherein said folic acid is selected from the group consisting of vitamin B9, folacin, metafolin, folate, (6S)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 5-methyl-(6S)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 5-formyl-(6S)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 10-formyl-(6R)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 5,10-methylene-(6R)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 5,10-methenyl-(6R)-tetrahydrofolic acid or a polyglutamyl derivative thereof and 5-formimino-(6S)-tetrahydrofolic acid or a polyglutamyl derivative thereof.

### Claim 3 (depends on 1)

The method of claim 1, wherein said first composition is substantially free of one or more of other added vitamins, added minerals, and added coenzymes.

### Claim 4 (depends on 1)

The method of claim 1, wherein said first composition further comprises a pharmaceutically acceptable carrier.

### Claim 5 (depends on 4)

The method of claim 4, wherein said pharmaceutically acceptable carrier is selected from one or more of the group consisting of binders, diluents, lubricants, glidants, colorants, emulsifiers, disintegrants, starches, water, oils, alcohols, preservatives and sugars.

### Claim 6 (depends on 1)

The method of claim 1, wherein said vitamin B6 is present in the range of about 15 mg to about 45 mg.

### Claim 7 (depends on 1)

The method of claim 1, wherein said vitamin B12 is present in the range of about 0.9 mg to about 2.7 mg.

### Claim 8 (depends on 1)

The method of claim 1, wherein said folic acid is present in the range of about 1.25 mg to about 3.75 mg.

### Claim 9 (depends on 1)

The method of claim 1, wherein said CoQ10 is present in the range of about 50 mg to about 150 mg.

### Claim 10 (depends on 1)

The method of claim 1, wherein said first composition comprises about 15 mg to about 45 mg vitamin B6; about 0.9 mg to about 2.7 mg vitamin B12; about 1.25 mg to about 3.75 mg folic acid; and about 50 mg to about 150 mg CoQ10.

### Claim 11 (depends on 1)

The method of claim 1, wherein said first composition comprises about 24 mg to about 36 mg vitamin B6; about 1.44 mg to about 2.16 mg vitamin B12; about 2 mg to about 3 mg folic acid; and about 80 mg to about 120 mg CoQ10.

### Claim 12 (depends on 1)

The method of claim 1, wherein said first composition comprises about 27 mg to about 33 mg vitamin B6; about 1.26 mg to about 1.98 mg vitamin B12; about 2.25 mg to about 2.75 mg folic acid; and about 90 mg to about 110 mg CoQ10.

### Claim 13 (depends on 12)

The method of claim 12, wherein said vitamin B6 is present in the amount of about 30 mg.

### Claim 14 (depends on 12)

The method of claim 12, wherein said vitamin B12 is present in the amount of about 1.8 mg.

### Claim 15 (depends on 12)

The method of claim 12, wherein said folic acid is present in the amount of about 2.5 mg.

### Claim 16 (depends on 12)

The method of claim 12, wherein said CoQ10 is present in the amount of about 100 mg.

### Claim 17 (depends on 1)

The method of claim 1, wherein said vitamin B6 is present in the amount of about 30 mg; said vitamin B12 is present in the amount of about 1.8 mg; said folic acid is present in the amount of about 2.5 mg; and said CoQ10 is present in the amount of about 100 mg.

### Claim 18 (depends on 1)

The method of claim 1, wherein said first composition is administered to said patient orally.

### Claim 19 (depends on 1)

The method of claim 1, wherein said first composition is administered to said patient to prevent, treat and/or alleviate the occurrence or negative effects of cardiovascular disease.

### Claim 20 (depends on 19)

The method of claim 19, wherein said cardiovascular disease is selected from one or more of the group consisting of congestive heart failure, ischemic heart disease, cardiomyopathy, and hypertension.

### Claim 21 (depends on 1)

The method of claim 1, wherein said second composition is substantially free of one or more of other added vitamins, added minerals, and added coenzymes.

### Claim 22 (depends on 1)

The method of claim 1, wherein said second composition further comprises a pharmaceutically acceptable carrier.

### Claim 23 (depends on 22)

The method of claim 22, wherein said pharmaceutically acceptable carrier is selected from one or more of the group consisting of binders, diluents, lubricants, glidants, colorants, emulsifiers, disintegrants, starches, water, oils, alcohols, preservatives and sugars.

### Claim 24 (depends on 1)

The method of claim 1, wherein said omega-3 fatty acids are enclosed within a gel-cap.

### Claim 25 (depends on 1)

The method of claim 1, wherein said omega-3 fatty acids are present in the amount of about 50 mg to about 150 mg.

### Claim 26 (depends on 1)

The method of claim 1, wherein said omega-3 fatty acids are present in the amount of about 75 mg to about 125 mg.

### Claim 27 (depends on 1)

The method of claim 1, wherein said omega-3 fatty acids are present in the amount of about 90 mg to about 110 mg.

### Claim 28 (depends on 1)

The method of claim 1, wherein said omega-3 fatty acids are present in the amount of about 100 mg.

### Claim 29 (depends on 1)

The method of claim 1, wherein said second composition is administered to said patient orally.

### Claim 30 (depends on 1)

The method of claim 1, wherein said second composition is administered to said patient to prevent, treat and/or alleviate the occurrence or negative effects of cardiovascular disease.

### Claim 31 (depends on 30)

The method of claim 30, wherein said cardiovascular disease is selected from one or more of the group consisting of ischemic heart disease, coronary artery disease, high blood pressure, arrhythmia, and thrombogenicity.

### Claim 32

A kit comprising:
a first composition comprising vitamin B6, vitamin B12, folic acid, and CoQ10; and
a second composition comprising omega-3 fatty acids;
wherein said first and second compositions are packaged for co-administration to a patient, in any order.

### Claim 33 (depends on 32)

The kit of claim 32, wherein said folic acid is selected from the group consisting of vitamin B9, folacin, metafolin, folate, (6S)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 5-methyl-(6S)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 5-formyl-(6S)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 10-formyl-(6R)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 5,10-methylene-(6R)-tetrahydrofolic acid or a polyglutamyl derivative thereof, 5,10-methenyl-(6R)-tetrahydrofolic acid or a polyglutamyl derivative thereof and 5-formimino-(6S)-tetrahydrofolic acid or a polyglutamyl derivative thereof.

### Claim 34 (depends on 32)

The kit of claim 32, wherein said first composition is substantially free of one or more of other added vitamins, added minerals, and added coenzymes.

### Claim 35 (depends on 32)

The kit of claim 32, wherein said first composition further comprises a pharmaceutically acceptable carrier.

### Claim 36 (depends on 35)

The kit of claim 35, wherein said pharmaceutically acceptable carrier is selected from one or more of the group consisting of binders, diluents, lubricants, glidants, colorants, emulsifiers, disintegrants, starches, water, oils, alcohols, preservatives and sugars.

### Claim 37 (depends on 32)

The kit of claim 32, wherein said vitamin B6 is present in the range of about 15 mg to about 45 mg.

### Claim 38 (depends on 32)

The kit of claim 32, wherein said vitamin B12 is present in the range of about 0.9 mg to about 2.7 mg.

### Claim 39 (depends on 32)

The kit of claim 32, wherein said folic acid is present in the range of about 1.25 mg to about 3.75 mg.

### Claim 40 (depends on 32)

The kit of claim 32, wherein said CoQ10 is present in the range of about 50 mg to about 150 mg.

### Claim 41 (depends on 32)

The kit of claim 32, wherein said first composition comprises about 15 mg to about 45 mg vitamin B6; about 0.9 mg to about 2.7 mg vitamin B12; about 1.25 mg to about 3.75 mg folic acid; and about 50 mg to about 150 mg CoQ10.

### Claim 42 (depends on 32)

The kit of claim 32, wherein said first composition comprises about 24 mg to about 36 mg vitamin B6; about 1.44 mg to about 2.16 mg vitamin B12; about 2 mg to about 3 mg folic acid; and about 80 mg to about 120 mg CoQ10.

### Claim 43 (depends on 32)

The kit of claim 32, wherein said first composition comprises about 27 mg to about 33 mg vitamin B6; about 1.26 mg to about 1.98 mg vitamin B12; about 2.25 mg to about 2.75 mg folic acid; and about 90 mg to about 110 mg CoQ10.

### Claim 44 (depends on 43)

The kit of claim 43, wherein said vitamin B6 is present in the amount of about 30 mg.

### Claim 45 (depends on 43)

The kit of claim 43, wherein said vitamin B12 is present in the amount of about 1.8 mg.

### Claim 46 (depends on 43)

The kit of claim 43, wherein said folic acid is present in the amount of about 2.5 mg.

### Claim 47 (depends on 43)

The kit of claim 43, wherein said CoQ10 is present in the amount of about 100 mg.

### Claim 48 (depends on 32)

The kit of claim 32, wherein said vitamin B6 is present in the amount of about 30 mg; said vitamin B12 is present in the amount of about 1.8 mg; said folic acid is present in the amount of about 2.5 mg; and said CoQ10 is present in the amount of about 100 mg.

### Claim 49 (depends on 32)

The kit of claim 32, wherein said first composition is administered to said patient orally.

### Claim 50 (depends on 32)

The kit of claim 32, wherein said first composition is administered to said patient to prevent, treat and/or alleviate the occurrence or negative effects of cardiovascular disease.

### Claim 51 (depends on 50)

The kit of claim 50, wherein said cardiovascular disease is selected from one or more of the group consisting of congestive heart failure, ischemic heart disease, cardiomyopathy, and hypertension.

### Claim 52 (depends on 32)

The kit of claim 32, wherein said second composition is substantially free of one or more of other added vitamins, added minerals, and added coenzymes.

### Claim 53 (depends on 32)

The kit of claim 32, wherein said second composition further comprises a pharmaceutically acceptable carrier.

### Claim 54 (depends on 53)

The kit of claim 53, wherein said pharmaceutically acceptable carrier is selected from one or more of the group consisting of binders, diluents, lubricants, glidants, colorants, emulsifiers, disintegrants, starches, water, oils, alcohols, preservatives and sugars.

### Claim 55 (depends on 32)

The kit of claim 32, wherein said omega-3 fatty acids are enclosed within a gel-cap.

### Claim 56 (depends on 32)

The kit of claim 32, wherein said omega-3 fatty acids are present in the amount of about 50 mg to about 150 mg.

### Claim 57 (depends on 32)

The kit of claim 32, wherein said omega-3 fatty acids are present in the amount of about 75 mg to about 125 mg.

### Claim 58 (depends on 32)

The kit of claim 32, wherein said omega-3 fatty acids are present in the amount of about 90 mg to about 110 mg.

### Claim 59 (depends on 32)

The kit of claim 32, wherein said omega-3 fatty acids are present in the amount of about 100 mg.

### Claim 60 (depends on 32)

The kit of claim 32, wherein said second composition is administered to said patient orally.

### Claim 61 (depends on 32)

The kit of claim 32, wherein said second composition is administered to said patient to prevent, treat and/or alleviate the occurrence or negative effects of cardiovascular disease.

### Claim 62 (depends on 61)

The kit of claim 61, wherein said cardiovascular disease is selected from one or more of the group consisting of ischemic heart disease, coronary artery disease, high blood pressure, arrhythmia, and thrombogenicity.

### Claim 63 (depends on 32)

The kit of claim 32, wherein said packaging is selected from the group consisting of bottles and blister packs.

### Claim 64 (depends on 63)

The kit of claim 63, wherein said bottles are sold together; one bottle containing said first composition and a second bottle containing said second composition.

### Claim 65 (depends on 63)

The kit of claim 63, wherein said bottles are sold separately; one bottle containing said first composition and a second bottle containing said second composition.

### Claim 66 (depends on 63)

The kit of claim 63, wherein said bottles containing said first composition and said second composition are advertised as more effective if co-administered.

### Claim 67 (depends on 66)

The kit of claim 66, wherein said advertisements are selected from one or more of the group consisting of internet, print, and product packaging advertisements.

### Claim 68 (depends on 63)

The kit of claim 63, wherein said blister packs are sold together and said blister packs comprise a first blister pack containing said first composition and a second blister pack containing said second composition.

### Claim 69 (depends on 63)

The kit of claim 63, wherein said blister pack contains both said first composition and said second composition paired together per unit dose.

### Claim 70 (depends on 63)

The kit of claim 63, wherein said blister packs are sold separately and said blister packs comprise a first blister pack containing said first composition and a second blister pack containing said second composition.

### Claim 71 (depends on 63)

The kit of claim 63 wherein said blister packs containing said first composition and said second composition are advertised as more effective if co-administered.

### Claim 72 (depends on 71)

The kit of claim 71 wherein said advertisements are selected from one or more of the group consisting of internet, print, and product packaging advertisements.

### Claim 73 (depends on 32)

The kit of claim 32, wherein said first composition and said second composition are co-administered to a patient.

### Claim 74 (depends on 73)

The kit of claim 73, wherein said first composition and said second composition are co-administered to said patient orally.

### Claim 75 (depends on 32)

The kit of claim 32, wherein said first composition said second composition are co-administered to a patient to prevent, treat and/or alleviate the occurrence or negative effects of cardiovascular disease.

### Claim 76 (depends on 75)

The kit of claim 75, wherein said cardiovascular disease is selected from one or more of the group consisting of congestive heart failure, ischemic heart disease, cardiomyopathy, hypertension, coronary artery disease, high blood pressure, arrhythmia, and thrombogenicity.

### Claim 77 (depends on 32)

A method comprising providing the kit of claim 32 to patients.
